Filing Details

Accession Number:
0001209191-14-007622
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-05 17:14:04
Reporting Period:
2014-02-05
Filing Date:
2014-02-05
Accepted Time:
2014-02-05 17:14:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
943431 Joshua Ruch C/O Rho Ventures
152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1082907 Habib Kairouz C/O Rho Ventures
152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1120545 Mark Leschly C/O Rho Ventures
152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1325385 Rho Capital Partners Llc C/O Rho Ventures
152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1419636 Rho Ventures Vi Lp 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1478944 Rmv Vi, L.l.c. C/O Rho Ventures
152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-05 2,442,239 $0.00 2,442,239 No 4 C Indirect See Footnote
Common Stock Acquisiton 2014-02-05 225,818 $11.00 2,668,057 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series D Preferred Stock Disposition 2014-02-05 6,105,598 $0.00 2,442,239 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The Series D Preferred Stock held by Rho Ventures VI, L.P. ("Ventures") automatically converted on a 1-for-2.5 basis into shares of common stock upon the closing of the issuer's initial public offering.
  2. These securities are owned directly by Ventures. RMV VI, L.L.C. ("RMV") is the general partner of Ventures and Rho Capital Partners LLC ("Partners") is the managing member of RMV. Mark Leschly, Habib Kairouz and Joshua Ruch are managing members of Partners and exercise shared voting and investment power with respect to the shares owned by Ventures. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its respective pecuniary interest therein.